Literature DB >> 203537

Requirement for macrophages for interferon to be effective against encephalomyocarditis virus infection of mice.

N Stebbing, K M Dawson, I J Lindley.   

Abstract

Suppression of macrophages in mice by treatments with silica or auro-thiomalate (Myocrisin) reduced production of serum interferon by polyriboinosinic acid:polyribocytidylic acid by 85 to 90%, indicating that this double-stranded polynucleotide caused interferon production primarily in macrophages. Suppression of macrophages in mice by silica or Myocrisin treatment did not significantly affect the susceptibility of mice to encephalomyocarditis virus, although at virus doses around 20 times the 50% lethal dose they died about 48 h earlier. Macrophage interferon protected mice from encephalomyocarditis virus infection at much lower doses than fibroblast interferon, and treatment of mice with silica or Myocrisin abolished the protection conferred by macrophage interferon, whereas these treatments had a much smaller effect on the protection afforded by fibroblast interferon. The requirement for macrophages for interferon to be effective in mice can explain why macrophage suppression can cause normally nonlethal viruses to kill adult mice.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203537      PMCID: PMC414039          DOI: 10.1128/iai.19.1.5-11.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  In vivo antiviral activity of polynucleotide mimics of strategic regions in viral RNA.

Authors:  N Stebbing; C A Grantham; I J Lindley; M A Eaton; N H Carey
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

2.  Modifications by sodium auro-thio-malate of the expression of virulence in mice by defined strains of Semliki Forest virus.

Authors:  K Allner; C J Bradish; R Fitzgeorge; N Nathanson
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

Review 3.  On the role of mononuclear phagocytes in immunity against viruses.

Authors:  A C Allison
Journal:  Prog Med Virol       Date:  1974

4.  Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.

Authors:  N Stebbing; C A Grantham; N H Carey
Journal:  J Gen Virol       Date:  1976-01       Impact factor: 3.891

5.  Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures.

Authors:  J L Virelizier; A C Allison
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

6.  Interaction of mouse peritoneal macrophages with different arboviruses in vitro.

Authors:  G van der Groen; D A Vanden Berghe; S R Pattyn
Journal:  J Gen Virol       Date:  1977-02       Impact factor: 3.891

7.  Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection.

Authors:  V G Edy; A Billiau; P De Somer
Journal:  J Gen Virol       Date:  1976-05       Impact factor: 3.891

8.  Protection of mice against encephalomyocarditis virus infection by preparations of transfer RNA.

Authors:  N Stebbing; C A Grantham; F Kaminski; I J Lindley
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

9.  Investigation of the anti-viral mechanism of poly I and poly C against encephalomyocarditis virus infection in the absence of interferon induction in mice.

Authors:  N Stebbing; C A Grantham; F Kaminski
Journal:  J Gen Virol       Date:  1976-07       Impact factor: 3.891

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  5 in total

1.  Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.

Authors:  D Robert; J P Quillon; B Ivanoff; Y Beaudry; R Fontanges; G Normier; A M Pinel; L D D'hinterland
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus.

Authors:  N Stebbing; I J Lindley
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.

Authors:  N Stebbing; I J Lindley; K M Dawson
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

4.  Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice.

Authors:  P K Weck; E Rinderknecht; D A Estell; N Stebbing
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

5.  Macrophage dependence of polyriboinosinic acid-polyribocytidylic acid-induced resistance to herpes simplex virus infection in mice.

Authors:  D Martinez; R J Lynch; J B Meeker; A K Field
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.